Five Prime Therapeutics, Inc. Product Trends & Analysis - 2015

1
Five Prime Therapeutics, Inc. Product Pipeline
Review - 2015
No. Pages 44
Published on October - 2015
2
.
Report Overview
About Five Prime Therapeutics, Inc.Product
Pipeline Review - 2015 Global Markets Directs,
Five Prime Therapeutics, Inc.Product Pipeline
Review - 2015, provides an overview of the Five
Prime Therapeutics, Inc.s pharmaceutical research
and development focus. This report provides
comprehensive information on the current
therapeutic developmental pipeline of Five Prime
Therapeutics, Inc.s, complete with comparative
analysis at various stages, therapeutics
assessment by drug target, mechanism of action
(MoA), route of administration (RoA) and molecule
type. It also reviews latest updates, and
featured news and press releases, along with
special features on late-stage and discontinued
projects. Global Markets Directs report features
investigational drugs from across globe covering
over 20 therapy areas and nearly 3,000
indications. The report is built using data and
information sourced from Global Markets Directs
proprietary databases, Company/University
websites, SEC filings, investor presentations and
featured press releases from company/university
sites and industry-specific third party sources,
put together by Global Markets Directs team. Get
Full Details On http//www.researchbeam.com/five
-prime-therapeutics-inc-product-pipeline-review-20
15-market
3
.
Report Overview
Drug profiles/records featured in the report
undergoes periodic updation following a stringent
set of processes that ensures that all the
profiles are updated with the latest set of
information. Additionally, processes including
live news deals tracking, browser based
alert-box and clinical trials registries tracking
ensure that the most recent developments are
captured on a real time basis. The report
enhances decision making capabilities and help to
create effective counter strategies to gain
competitive advantage. It strengthens RD
pipelines by identifying new targets and MOAs to
produce first-in-class and best-in-class
products. Note Certain sections in the report
may be removed or altered based on the
availability and relevance of data for the
indicated disease. Scope The report provides
brief overview of Five Prime Therapeutics,
Inc.including business description, key
information and facts, and its locations and
subsidiaries The report reviews current pipeline
of Five Prime Therapeutics, Inc.s human
therapeutic division and enlists all their major
and minor projects
4
.
Report Overview
The report features product description and
descriptive mechanism of action for key pipeline
products along with the products developmental
history and major milestones Special feature on
out-licensed and partnered product portfolio The
report summarizes all the dormant and
discontinued pipeline projects Latest company
statement Latest news and deals relating to the
Five Prime Therapeutics, Inc.s pipeline
products   Reasons to buy Evaluate Five Prime
Therapeutics, Inc.s strategic position with total
access to detailed information on its product
pipeline Assess the growth potential of Five
Prime Therapeutics, Inc.in its therapy areas of
focus Identify new drug targets and therapeutic
classes in the Five Prime Therapeutics, Inc.s RD
portfolio and develop key strategic initiatives
to reinforce pipeline in those areas Exploit
in-licensing opportunities by identifying windows
of opportunity to fill portfolio gaps
5
Report Overview

• Develop strategic initiatives by understanding
  the focus areas of Five Prime Therapeutics,
  Inc.and exploit collaboration and partnership
  opportunities
• Identify emerging players with potentially strong
  product portfolio and create effective
  counter-strategies to gain competitive advantage
• Plan mergers and acquisitions effectively by
  identifying the most promising pipeline of Five
  Prime Therapeutics, Inc.
• Develop and design in-licensing and out-licensing
  strategies by identifying prospective partners
  with the most attractive projects to enhance and
  expand business potential and Scope
• Explore the dormant and discontinued projects of
  Five Prime Therapeutics, Inc.and identify
  potential opportunities in those areas
• Avoid Intellectual Property Rights related issues

6
Table Of Contents
List of Tables 4List of Figures 4Five Prime
Therapeutics, Inc. Snapshot 5Five Prime
Therapeutics, Inc. Overview 5Key Information
5Key Facts 5Five Prime Therapeutics, Inc. -
Research and Development Overview 6Key
Therapeutic Areas 6Five Prime Therapeutics, Inc.
- Pipeline Review 8Pipeline Products by Stage of
Development 8Pipeline Products - Monotherapy
9Pipeline Products - Partnered Products
10Partnered Products/Combination Treatment
Modalities 11Pipeline Products - Out-Licensed
Products 12
7
Table Of Contents
Out-Licensed Products/Combination Treatment
Modalities 13Five Prime Therapeutics, Inc. -
Pipeline Products Glance 14Five Prime
Therapeutics, Inc. - Clinical Stage Pipeline
Products 14 Phase I Products/Combination
Treatment Modalities 14 Five Prime Therapeutics,
Inc. - Early Stage Pipeline Products
15Preclinical Products/Combination Treatment
Modalities 15Discovery Products/Combination
Treatment Modalities 16Five Prime Therapeutics,
Inc. - Drug Profiles 17FPA-008 17Product
Description 17Mechanism of Action 17RD
Progress 17
8
Table Of Contents
FP-1039 19Product Description 19Mechanism of
Action 19RD Progress 19FPA-144 21 Product
Description 21Mechanism of Action 21RD
Progress 21INBRX-110 23Product Description
23Mechanism of Action 23RD Progress 23Enquiry
about this report _at_ http//www.researchbeam.com/fi
ve-prime-therapeutics-inc-product-pipeline-review-
2015-market/enquire-about-report
9
FOR MORE DETAILS
Visit us at
http//www.researchbeam.com/five-prime-therapeutic
s-inc-product-pipeline-review-2015-market
Stay With Us
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
TELEPHONE [phone] E-MAIL
sales_at_researchbeam.com